Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/4192 stock hub

TPEX/4192 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4192is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

720.9M

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4192

In the news

Latest news · TPEX/4192

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-16.9

P25 -16.2P50 0.3P75 9.8

ROIC-10.7

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4192 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

TWD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	40
Employees Change	-10%
Employees Change Percent	-20
Enterprise value	TWD 558.4M
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0004192000
Last refreshed	2026-05-10
Market cap	TWD 720.9M
Price	TWD 20.5
Price currency	TWD
Rev Per Employee	676,075x
Sector	Healthcare
Sic	2834
Symbol	tpex/4192
Website	https://www.syncorebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.35%
EV Earnings	-12.2x
EV/FCF	-14.48x
EV/Sales	20.65x
FCF yield	-5.35%
P/B ratio	2.93x
P/S ratio	26.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-174.52%
EBITDA Margin	-145.6%
Gross margin	77.98%
Gross Profit	TWD 21.1M
Gross Profit Growth	63.64%
Gross Profit Growth Q	55.15%
Gross Profit Growth3 Y	32.4%
Gross Profit Growth5 Y	27.78%
Net Income	TWD -45.8M
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Pretax Margin	-169.19%
Profit Margin	-169.19%
Profit Per Employee	TWD -1.1M
ROA	-10.29
Roa5y	-15.92
ROCE	-19.21
ROE	-16.94
Roe5y	-38.42
ROIC	-10.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-17.26%
Cagr1y	-30.53%
Cagr3y	-34.16%
Cagr5y	-35.83%
EPS Growth Years	0
Revenue Growth	15.88x
Revenue Growth Q	11.93x
Revenue Growth Quarters	5x
Revenue Growth Years	4x
Revenue Growth3 Y	19.48x
Revenue Growth5 Y	15.19x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.09
Assets	TWD 255.7M
Cash	TWD 164.4M
Current Assets	TWD 215.3M
Current Liabilities	TWD 10.1M
Debt	TWD 2M
Debt Equity	TWD 0.01
Debt FCF	TWD -0.05
Equity	TWD 245.6M
Interest Coverage	-272.8
Liabilities	TWD 10.1M
Long Term Assets	TWD 40.4M
Long Term Liabilities	TWD 0
Net Cash	TWD 162.5M
Net Cash By Market Cap	TWD 22.54
Net Cash Growth	-20.62%
Net Debt Equity	TWD -0.66
Tangible Book Value	TWD 208.6M
Tangible Book Value Per Share	TWD 5.93
WACC	5.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	21.37
Inventory Turnover	0.6
Net Working Capital	TWD 42.7M
Quick ratio	20.24
Working Capital	TWD 205.2M
Working Capital Turnover	TWD 0.12

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-84.96%
1Y total return	-30.51%
200-day SMA	25.2
3Y total return	-71.47%
50-day SMA	20.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-89.11%
All Time High	580.2
All Time High Change	-96.47%
All Time High Date	2020-07-10
All Time Low	19
All Time Low Change	7.89%
All Time Low Date	2026-05-04
ATR	0.62
Beta	0.29
Beta1y	0.31
Beta2y	0.4
Ch YTD	-17.67
High	20.8
High52	30.35
High52 Date	2025-06-12
High52ch	-32.45%
Low	20
Low52	19
Low52 Date	2026-05-04
Low52ch	7.9%
Ma50ch	-0.96%
Price vs 200-day SMA	-18.65%
RSI	51.32
RSI Monthly	30.05
RSI Weekly	28.15
Sharpe ratio	-1.45x
Sortino ratio	-1.74
Tr YTD	-17.67
Tr1m	0.24%
Tr1w	-0.49%
Tr3m	-6.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -47.2M
Operating margin	-174.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,007,015%
Net Borrowing	-9,630,000
Shares Insiders	0.97%
Shares Institutions	0.92%
Shares Out	35,164,500
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -38.6M
Average Volume	15,773.4x
Bv Per Share	6.99
CAPEX	TWD -232,000
Ch10y	-85.28
Ch1m	0.24
Ch1w	-0.49
Ch1y	-30.51
Ch3m	-6.82
Ch3y	-71.91
Ch5y	-89.28
Ch6m	-19.13
Change	-1.44%
Change From Open	1.99
Close	20.8
Days Gap	-3.37
Depreciation Amortization	7,822,000
Dollar Volume	430,725.5
Earnings Date	2026-05-12
EBIT	TWD -47.2M
EBITDA	TWD -39.4M
EPS	TWD -1.3
F Score	4
FCF	TWD -38.6M
FCF EV Yield	-6.91x
FCF Per Share	TWD -1.1
Financing CF	-9,630,000
Fiscal Year End	December
Founded	2,008
Investing CF	-252,000
Is Primary Listing	1
Last Earnings Date	2026-01-27
Last Report Date	2025-12-31
Last Split Date	2023-06-29
Last Split Type	Reverse
Ma150	24.23
Ma150ch	-15.39%
Ma20	20.21
Ma20ch	1.42%
Net CF	-48,153,000
Next Earnings Date	2026-05-12
Open	20.1
Position In Range	62.5
Ppne	3,005,000
Price Date	2026-05-08
Ptbv Ratio	3.46
Relative Volume	1.42x
Revenue	27,043,000x
Tr6m	-19.13%
Volume	21,011
Z Score	61.41

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/4192 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/4192 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4192?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.9%

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TPEX/4192 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.3

Neutral momentum band

Price vs 200-day MA

-18.7%

50/200-day relationship not available

Beta (5Y)

0.29

Less volatile than the market

Sharpe ratio

-1.45

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4192

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4192 stock rating?

tpex/4192 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4192 analysis?

The full report lives at /stocks/tpex/4192/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4192?

The latest report frames tpex/4192 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4192 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.